|
1
|
Parkin DM: Global cancer statistics in the
year 2000. Lancet Oncol. 2:533–543. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li G, Yang D, Li X, Zhong K, Liu X, Bi M,
Liu Y, Liao X and Lin L: Expression of SATB1 in hepatocellular
carcinoma cell lines with different invasive capacities. Nan Fang
Yi Ke Da Xue Xue Bao. 32:986–994. 2012.(In Chinese). PubMed/NCBI
|
|
3
|
Xu L, Deng HX, Xia JH, Yang Y, Fan CH,
Hung WY and Siddque T: Assignment of SATB1 to human chromosome band
3p23 by in situ hybridization. Cytogenet Cell Genet. 77:205–206.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dickinson LA, Joh T, Kohwi Y and
Kohwi-Shigematsu T: A tissue-specific MAR/SAR DNA-binding protein
with unusual binding site recognition. Cell. 70:631–645. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wen J, Huang S, Rogers H, Dickinson LA,
Kohwi-Shigematsu T and Noguchi CT: SATB1 family protein expressed
during early erythroid differentiation modifies globin gene
expression. Blood. 105:3330–3339. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kumar PP, Purbey PK, Ravi DS, Mitra D and
Galande S: Displacement of SATB1-bound histone deacetylase 1
corepressor by the human immunodeficiency virus type 1
transactivator induces expression of interleukin-2 and its receptor
in T cells. Mol Cell Biol. 25:1620–1633. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yasui D, Miyano M, Cai S, Varga-Weisz P
and Kohwi-Shigematsu T: SATB1 targets chromatin remodelling to
regulate genes over long distances. Nature. 419:641–645. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang Z, Yang X, Chu X, Zhang J, Zhou H,
Shen Y and Long J: The structural basis for the oligomerization of
the N-terminal domain of SATB1. Nucleic Acids Res. 40:4193–4202.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kumar PP, Bischof O, Purbey PK, Notani D,
Urlaub H, Dejean A and Galande S: Functional interaction between
PML and SATB1 regulates chromatin-loop architecture and
transcription of the MHC class I locus. Nat Cell Biol. 9:45–56.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Galande S, Purbey PK, Notani D and Kumar
PP: The third dimension of gene regulation: Organization of dynamic
chromatin loopscape by SATB1. Curr Opin Genet Dev. 17:408–414.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Beyer M, Thabet Y, Müller RU, Sadlon T,
Classen S, Lahl K, Basu S, Zhou X, Bailey-Bucktrout SL, Krebs W, et
al: Repression of the genome organizer SATB1 in regulatory T cells
is required for suppressive function and inhibition of effector
differentiation. Nat Immunol. 12:898–907. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Notani D, Gottimukkala KP, Jayani RS,
Limaye AS, Damle MV, Mehta S, Purbey PK, Joseph J and Galande S:
Global regulator SATB1 recruits beta-catenin and regulates T(H)2
differentiation in Wnt-dependent manner. PLoS Biol. 8:e10002962010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Han HJ, Russo J, Kohwi Y and
Kohwi-Shigematsu T: SATB1 reprogrammes gene expression to promote
breast tumour growth and metastasis. Nature. 452:187–193. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hanker LC, Karn T, Mavrova-Risteska L,
Ruckhäberle E, Gaetje R, Holtrich U, Kaufmann M, Rody A and
Wiegratz I: SATB1 gene expression and breast cancer prognosis.
Breast. 20:309–313. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li QQ, Chen ZQ, Cao XX, Xu JD, Xu JW, Chen
YY, Wang WJ, Chen Q, Tang F, Liu XP and Xu ZD: Involvement of
NF-κB/miR-448 regulatory feedback loop in chemotherapy-induced
epithelial-mesenchymal transition of breast cancer cells. Cell
Death Differ. 18:16–25. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nodin B, Hedner C, Uhlén M and Jirström K:
Expression of the global regulator SATB1 is an independent factor
of poor prognosis in high grade epithelial ovarian cancer. J
Ovarian Res. 5:242012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sun F, Lu X, Li H, Peng Z, Wu K, Wang G
and Tong Q: Special AT-rich sequence binding protein 1 regulates
the multidrug resistance and invasion of human gastric cancer
cells. Oncol Lett. 4:156–162. 2012.PubMed/NCBI
|
|
18
|
Nodin B, Johannesson H, Wangefjord S,
O'Connor DP, Lindquist KE, Uhlén M, Jirström K and Eberhard J:
Molecular correlates and prognostic significance of SATB1
expression in colorectal cancer. Diagn Pathol. 7:1152012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang J, Zhang B, Zhang X, Sun Y, Wei X,
McNutt MA, Lu S, Liu Y, Zhang D, Wang M, et al: SATB1 expression is
associated with biologic behavior in colorectal carcinoma in vitro
and in vivo. PloS One. 8:e479022013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Meng WJ, Yan H, Zhou B, Zhang W, Kong XH,
Wang R, Zhan L, Li Y, Zhou ZG and Sun XF: Correlation of SATB1
overexpression with the progression of human rectal cancer. Int J
Colorectal Dis. 27:143–150. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chu SH, Ma YB, Feng DF, Zhang H, Zhu ZA,
Li ZQ and Jiang PC: Upregulation of SATB1 is associated with the
development and progression of glioma. J Transl Med. 10:1492012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu Y, van den Berg A, Veenstra R, Rutgers
B, Nolte I, van Imhoff G, Visser L and Diepstra A: PML nuclear
bodies and SATB1 are associated with HLA class I expression in EBV+
Hodgkin lymphoma. PloS One. 8:e729302013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Huang B, Zhou H, Wang X and Liu Z:
Silencing SATB1 with siRNA inhibits the proliferation and invasion
of small cell lung cancer cells. Cancer Cell Int. 13:82013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shukla S, Sharma H, Abbas A, MacLennan GT,
Fu P, Danielpour D and Gupta S: Upregulation of SATB1 is associated
with prostate cancer aggressiveness and disease progression. PloS
One. 8:e535272013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mao L, Yang C, Wang J, Li W, Wen R, Chen J
and Zheng J: SATB1 is overexpressed in metastatic prostate cancer
and promotes prostate cancer cell growth and invasion. J Transl
Med. 11:1112013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tu W, Luo M, Wang Z, Yan W, Xia Y, Deng H,
He J, Han P and Tian D: Upregulation of SATB1 promotes tumor growth
and metastasis in liver cancer. Liver Int. 32:1064–1078. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bosman FT, Carneiro F, Hruban RH and
Theise ND: WHO Classification of Tumours of the Digestive System.
4th. World Health Organization; pp. 4172010
|
|
28
|
Liang CC, Park AY and Guan JL: In vitro
scratch assay: A convenient and inexpensive method for analysis of
cell migration in vitro. Nat Protoc. 2:329–333. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Obermajer N, Doljak B and Kos J:
Cytokeratin 8 ectoplasmic domain binds urokinase-type plasminogen
activator to breast tumor cells and modulates their adhesion,
growth and invasiveness. Mol Cancer. 8:882009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cheng J, Huo DH, Kuang DM, Yang J, Zheng L
and Zhuang SM: Human macrophages promote the motility and
invasiveness of osteopontin-knockdown tumor cells. Cancer Res.
67:5141–5147. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li Y, Tang Y, Ye L, Liu B, Liu K, Chen J
and Xue Q: Establishment of a hepatocellular carcinoma cell line
with unique metastatic characteristics through in vivo selection
and screening for metastasis-related genes through cDNA microarray.
J Cancer Res Clin Oncol. 129:43–51. 2003.PubMed/NCBI
|
